West Branch Capital LLC Abb Vie Inc. Transaction History

West Branch Capital LLC

$234 Million
Q1 2024

A detailed history of West Branch Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, West Branch Capital LLC holds 29,644 shares of ABBV stock, worth $4.94 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

29,644

Previous 29,244 1.37%

Holding current value

$4.94 Million

Previous $4.53 Million 19.13%

% of portfolio

2.3%

Previous 2.26%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $63,928 - $72,840	400 Added 1.37%	29,644 $5.4 Million
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $15,548 - $17,511	113 Added 0.39%	29,244 $4.53 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $21,908 - $25,362	164 Added 0.57%	29,131 $4.34 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $17,226 - $21,437	130 Added 0.45%	28,967 $3.9 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $289 - $333	-2 Reduced 0.01%	28,837 $4.6 Million

Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $276 - $331	-2 Reduced 0.01%	28,839 $0
Q3 2022 Oct 19, 2022	SELL	$134.21 - $153.93 $4,294 - $4,925	-32 Reduced 0.11%	28,841 $3.87 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $2,890 - $3,674	-21 Reduced 0.07%	28,873 $4.42 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $31,147 - $38,645	-236 Reduced 0.81%	28,894 $4.68 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $214 - $271	-2 Reduced 0.01%	29,130 $3.94 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $242,060 - $274,774	2,275 Added 8.47%	29,132 $3.14 Million
Q2 2021 Aug 17, 2021	BUY	$105.21 - $117.21 $60,390 - $67,278	574 Added 2.18%	26,857 $3.03 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $93,195 - $102,596	-911 Reduced 3.35%	26,283 $2.84 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $4,748 - $6,411	-59 Reduced 0.22%	27,194 $2.91 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $22,250 - $26,114	259 Added 0.96%	27,253 $2.39 Million
Q2 2020 Jul 08, 2020	BUY	$73.37 - $98.18 $32,943 - $44,082	449 Added 1.69%	26,994 $2.65 Million
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $68,434 - $103,755	-1,061 Reduced 3.84%	26,545 $2.02 Million
Q4 2019 Jan 07, 2020	SELL	$72.13 - $90.25 $286,211 - $358,112	-3,968 Reduced 12.57%	27,606 $2.44 Million
Q3 2019 Oct 23, 2019	BUY	$62.98 - $75.72 $434,750 - $522,695	6,903 Added 27.98%	31,574 $2.39 Million
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $311,418 - $398,065	-4,740 Reduced 16.12%	24,671 $1.79 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $156,671 - $184,394	2,031 Added 7.42%	29,411 $2.37 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $62,824 - $77,480	-807 Reduced 2.86%	27,380 $2.52 Million
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $130,075 - $144,602	-1,463 Reduced 4.93%	28,187 $2.67 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $303,007 - $358,526	3,375 Added 12.84%	29,650 $2.75 Million
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $2.42 Million - $3.24 Million	26,275 New	26,275 $2.49 Million

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.

Account

West Branch Capital LLC Abb Vie Inc. Transaction History